One thing that must never be underestimated about the immunotherapy being researched is its potential application to the MAJORITY of all cancers is where the blue sky opportunity arises (this is the only real way this stock will ever reach $10)..
As for market valuation, it was explained to you RR very clearly and lengthy by several posters in the previous post. Why are you back again asking the very same thing? Go look at valuations of other biotech researchers, apply the same model and you may see the value..
$1 billion market cap at $1 per share...., page-41
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.020(6.25%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 29.5¢ | $2.355M | 7.796M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 128197 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |